샘플 요청 목록

 카트 문의
시장보고서
상품코드
1656236

세계의 헬스케어 분야 메타버스 시장

Metaverse in Healthcare
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 210 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

헬스케어 분야 메타버스 세계 시장은 2030년까지 1,591억 달러에 달할 전망

2024년에 154억 달러로 추정되는 헬스케어 분야 메타버스 세계 시장은 2030년에는 1,591억 달러에 달할 것으로 예측되며, 분석기간인 2024-2030년 CAGR은 47.6%로 성장할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 메타버스 소프트웨어는 CAGR 51.2%를 기록하며 분석기간 종료시에는 915억 달러에 달할 것으로 예측됩니다. 메타버스 하드웨어 부문의 성장률은 분석기간 동안 CAGR 41.1%로 추정됩니다.

미국 시장은 44억 달러, 중국은 CAGR 43.7%로 성장 예측

미국의 헬스케어 분야 메타버스 시장은 2024년에 44억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 212억 달러의 시장 규모에 달할 것으로 예측되며, 분석기간인 2024-2030년 CAGR은 43.7%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석기간 동안 CAGR은 각각 42.7%와 39.1%로 예측됩니다. 유럽에서는 독일이 CAGR 약 30.5%로 성장할 것으로 예측됩니다.

세계의 헬스케어 분야 메타버스 시장 - 주요 동향과 촉진요인 정리

메타버스는 최첨단 기술과 디지털 플랫폼을 결합하여 의료 서비스 제공과 상호작용을 혁신함으로써 헬스케어 산업에 혁명을 일으키고자 합니다. 이 새로운 분야는 가상과 물리적 영역의 경계를 허물고 몰입형 가상현실(VR) 환경과 3D 모델링을 통해 의료 교육, 수술 계획, 정신과 치료의 획기적인 발전을 약속하고 있습니다. 걸프협력회의(GCC) 국가들, 특히 사우디아라비아와 아랍에미리트연합(UAE)은 이러한 기술 혁신의 선두에 서 있으며, 광범위한 국가 혁신 프로그램의 일환으로 이러한 기술을 의료 시스템에 통합하고 있습니다. 두바이 최초의 메타버스 병원(Metaverse Hospital)과 아부다비의 생명과학 허브(Life Science Hub)와 같은 프로젝트는 가상과 물리적 의료 서비스를 통합하는 선구자 역할을 하고 있습니다.

VR, 증강현실(AR), 혼합현실(MR)의 기술 발전은 의료 전문가가 가상 진료와 시술을 할 수 있는 몰입형 환경을 제공하는 데 있어 매우 중요하며, COVID-19 팬데믹은 원격의료 서비스의 채택을 크게 가속화시켰고, 메타버스가 촉진하는 보다 정교한 몰입형 원격의료 경험에 대한 수요를 증가시켰습니다. 원격의료 서비스의 채택을 크게 가속화하고, 메타버스가 촉진하는 보다 정교하고 몰입감 있는 원격의료 경험에 대한 수요를 증가시켰습니다. 또한, 메타버스는 의료 훈련과 교육을 위한 혁신적인 플랫폼을 제공하여 의대생들이 실제 세계에서 재현하기 어려운 인터랙티브한 학습 시나리오를 연습하고, 안전하고 확장 가능한 환경을 제공합니다. 또한, 가상 환경을 통해 얻을 수 있는 운영 효율성은 물리적 공간의 필요성과 관련 비용을 절감하고, 자원 관리를 강화하며, 의료 전문가의 이동 시간과 일정 충돌을 줄일 수 있습니다.

헬스케어 분야에서 메타버스의 잠재력은 환자 참여와 개별화 치료에도 적용되어 가상 환경에서 개인별 맞춤 치료 세션과 웰니스 프로그램을 제공함으로써 환자 만족도와 결과를 향상시킬 수 있습니다. 메타버스가 촉진하는 세계 협업을 통해 전 세계 의료 서비스 제공자들은 지식과 전문지식을 보다 쉽게 공유할 수 있게 되어 치료의 질과 공중보건 문제에 대한 대응력을 강화할 수 있습니다. 고급 데이터 분석과 인공지능을 메타버스에 통합하면 의료 데이터 관리가 강화되어 개인화된 치료 계획과 예측 의료를 개발하는 데 도움이 됩니다. 이러한 장점에도 불구하고, 메타버스가 의료계에 성공적으로 통합되기 위해서는 데이터 프라이버시 문제, 규제 프레임워크의 필요성, 의료 종사자들의 신기술 수용성 등 여러 가지 도전과제에 직면해 있습니다. 이러한 문제를 해결하고, 데이터 보안을 강화하며, 규제를 명확히 하는 것은 메타버스의 헬스케어 혁신의 잠재력을 완전히 실현하는 데 매우 중요합니다.

부문

구성요소(소프트웨어, 하드웨어, 서비스), 기술(증강/가상현실, 인공지능, 블록체인, 혼합현실, 기타 기술), 응용 분야(의료 교육/수술 훈련, 신약개발/맞춤형 의료, 디지털 치료, 원격의료/원격치료, 기타 애플리케이션), 최종사용자(헬스케어 제공자, 환자, 제약/바이오기업, 기타 최종사용자)

조사 대상 기업 사례(주목 23개사)

  • Accenture PLC
  • Antier Solutions Pvt Ltd
  • Appinventiv
  • EON Reality, Inc.
  • ImmersiveTouch
  • Inovalon Holdings, Inc.
  • LeewayHertz
  • Siemens Healthineers AG
  • Wipro Ltd.
  • XRHealth

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 성장 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

ksm 25.03.06

Global Metaverse in Healthcare Market to Reach US$159.1 Billion by 2030

The global market for Metaverse in Healthcare estimated at US$15.4 Billion in the year 2024, is expected to reach US$159.1 Billion by 2030, growing at a CAGR of 47.6% over the analysis period 2024-2030. Metaverse Software, one of the segments analyzed in the report, is expected to record a 51.2% CAGR and reach US$91.5 Billion by the end of the analysis period. Growth in the Metaverse Hardware segment is estimated at 41.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.4 Billion While China is Forecast to Grow at 43.7% CAGR

The Metaverse in Healthcare market in the U.S. is estimated at US$4.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$21.2 Billion by the year 2030 trailing a CAGR of 43.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 42.7% and 39.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 30.5% CAGR.

Global Metaverse in Healthcare Market - Key Trends and Drivers Summarized

The metaverse is set to revolutionize the healthcare industry by merging cutting-edge technologies with digital platforms to transform healthcare delivery and interactions. This emerging field blurs the lines between virtual and physical realms, promising significant advancements in medical training, surgical planning, and psychiatric therapy through immersive virtual reality (VR) environments and 3D modeling. The Gulf Cooperation Council (GCC) countries, particularly Saudi Arabia and the United Arab Emirates, are at the forefront of this innovation, embedding these technologies within their healthcare systems as part of broader national transformation programs. These initiatives aim not only to enhance public health services but also to capitalize on the digital economic growth, with projects like Dubai’s first hospital in the metaverse and Abu Dhabi’s Life Science Hub pioneering the integration of virtual and physical healthcare services.

Several key drivers are propelling the growth of the metaverse in healthcare. Technological advancements in VR, augmented reality (AR), and mixed reality (MR) are crucial, enabling immersive environments that allow medical professionals to perform virtual consultations and procedures. The COVID-19 pandemic has significantly accelerated the adoption of telehealth services, increasing demand for more sophisticated, immersive telehealth experiences facilitated by the metaverse. Moreover, the metaverse offers transformative platforms for medical training and education, providing a safe, scalable environment where medical students can practice procedures and engage in interactive learning scenarios that are otherwise challenging to replicate in the real world. Additionally, operational efficiencies gained through virtual environments can reduce physical space needs and associated costs, while enhancing resource management and reducing travel time and scheduling conflicts for healthcare professionals.

The potential of the metaverse in healthcare extends into patient engagement and personalized care, offering customized therapy sessions and wellness programs in virtual settings tailored to individual needs, thereby improving patient satisfaction and outcomes. Global collaboration facilitated by the metaverse allows healthcare providers worldwide to share knowledge and expertise more easily, enhancing the quality of care and response to public health challenges. Integrating advanced data analytics and artificial intelligence within the metaverse enhances medical data management and aids in developing personalized treatment plans and predictive healthcare. Despite these advantages, the successful integration of the metaverse into mainstream healthcare practices faces challenges such as data privacy concerns, the need for regulatory frameworks, and the readiness of healthcare professionals to embrace new technologies. Addressing these challenges, enhancing data security, and fostering regulatory clarity are crucial for fully realizing the metaverse's potential in transforming healthcare.

SCOPE OF STUDY:

The report analyzes the Metaverse in Healthcare market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Software, Hardware, Services); Technology (Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality, Other Technologies); Application (Medical Education & Surgical Training, Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications); End-User (Healthcare Providers, Patients, Pharma & Biopharma Companies, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 23 Featured) -

  • Accenture PLC
  • Antier Solutions Pvt Ltd
  • Appinventiv
  • EON Reality, Inc.
  • ImmersiveTouch
  • Inovalon Holdings, Inc.
  • LeewayHertz
  • Siemens Healthineers AG
  • Wipro Ltd.
  • XRHealth

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Metaverse in Healthcare - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Interest Grows in AR/VR Integration into Remote Patient Monitoring & Other Healthcare Settings
    • Increased Telehealth Adoption Drives Growth in Metaverse Platforms
    • Digital Twins in Surgery Planning is the New Way Forward
    • Metaverse for Medical Education Expands Addressable Market Opportunity
    • Patient Engagement Platforms Enhanced by Metaverse Technologies Generate Demand
    • 3D Virtual Clinics Strengthen the Business Case for Metaverse in Healthcare
    • AI and IoT Integration in Metaverse Spurs Comprehensive Healthcare Solutions
    • Metaverse's Role in Mental Health Therapy Expands Usage Scenarios
    • Blockchain for Secure Health Data Management in the Metaverse
    • Gamification of Health Programs Through Metaverse Drives Patient Participation
    • Enhanced Access to Healthcare in Rural Areas Via Metaverse Platforms
    • Metaverse Interfaces for Disabled Patients Enhance Accessibility
    • Data Privacy Concerns in the Metaverse Shape Regulatory Developments
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Metaverse in Healthcare Market Analysis of Annual Sales in US$ Million for Years 2022 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Metaverse in Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Metaverse in Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 4: World 8-Year Perspective for Metaverse in Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2022, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 7: World 8-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 10: World 8-Year Perspective for Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 13: World 8-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Drug Discovery & Personalized Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Drug Discovery & Personalized Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 16: World 8-Year Perspective for Drug Discovery & Personalized Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Digital Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Digital Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 19: World 8-Year Perspective for Digital Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Telehealth & Telemedicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Telehealth & Telemedicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 22: World 8-Year Perspective for Telehealth & Telemedicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 25: World 8-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Medical Education & Surgical Training by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Medical Education & Surgical Training by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 28: World 8-Year Perspective for Medical Education & Surgical Training by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Healthcare Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Healthcare Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 31: World 8-Year Perspective for Healthcare Providers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 34: World 8-Year Perspective for Patients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 37: World 8-Year Perspective for Pharma & Biopharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 40: World 8-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Augmented / Virtual Reality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Augmented / Virtual Reality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 43: World 8-Year Perspective for Augmented / Virtual Reality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Artificial Intelligence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Artificial Intelligence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 46: World 8-Year Perspective for Artificial Intelligence by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Blockchain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Blockchain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 49: World 8-Year Perspective for Blockchain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 50: World Recent Past, Current & Future Analysis for Mixed Reality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: World Historic Review for Mixed Reality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 52: World 8-Year Perspective for Mixed Reality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 53: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 55: World 8-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Metaverse in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 56: USA Recent Past, Current & Future Analysis for Metaverse in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for Metaverse in Healthcare by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 58: USA 8-Year Perspective for Metaverse in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2025 & 2030
    • TABLE 59: USA Recent Past, Current & Future Analysis for Metaverse in Healthcare by Application - Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: USA Historic Review for Metaverse in Healthcare by Application - Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 61: USA 8-Year Perspective for Metaverse in Healthcare by Application - Percentage Breakdown of Value Sales for Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training for the Years 2022, 2025 & 2030
    • TABLE 62: USA Recent Past, Current & Future Analysis for Metaverse in Healthcare by End-user - Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: USA Historic Review for Metaverse in Healthcare by End-user - Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 64: USA 8-Year Perspective for Metaverse in Healthcare by End-user - Percentage Breakdown of Value Sales for Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 65: USA Recent Past, Current & Future Analysis for Metaverse in Healthcare by Technology - Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: USA Historic Review for Metaverse in Healthcare by Technology - Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 67: USA 8-Year Perspective for Metaverse in Healthcare by Technology - Percentage Breakdown of Value Sales for Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies for the Years 2022, 2025 & 2030
  • CANADA
    • TABLE 68: Canada Recent Past, Current & Future Analysis for Metaverse in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Canada Historic Review for Metaverse in Healthcare by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 70: Canada 8-Year Perspective for Metaverse in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2025 & 2030
    • TABLE 71: Canada Recent Past, Current & Future Analysis for Metaverse in Healthcare by Application - Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Canada Historic Review for Metaverse in Healthcare by Application - Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 73: Canada 8-Year Perspective for Metaverse in Healthcare by Application - Percentage Breakdown of Value Sales for Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training for the Years 2022, 2025 & 2030
    • TABLE 74: Canada Recent Past, Current & Future Analysis for Metaverse in Healthcare by End-user - Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Canada Historic Review for Metaverse in Healthcare by End-user - Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 76: Canada 8-Year Perspective for Metaverse in Healthcare by End-user - Percentage Breakdown of Value Sales for Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 77: Canada Recent Past, Current & Future Analysis for Metaverse in Healthcare by Technology - Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Canada Historic Review for Metaverse in Healthcare by Technology - Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 79: Canada 8-Year Perspective for Metaverse in Healthcare by Technology - Percentage Breakdown of Value Sales for Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies for the Years 2022, 2025 & 2030
  • JAPAN
    • Metaverse in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 80: Japan Recent Past, Current & Future Analysis for Metaverse in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Japan Historic Review for Metaverse in Healthcare by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 82: Japan 8-Year Perspective for Metaverse in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2025 & 2030
    • TABLE 83: Japan Recent Past, Current & Future Analysis for Metaverse in Healthcare by Application - Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Japan Historic Review for Metaverse in Healthcare by Application - Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 85: Japan 8-Year Perspective for Metaverse in Healthcare by Application - Percentage Breakdown of Value Sales for Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training for the Years 2022, 2025 & 2030
    • TABLE 86: Japan Recent Past, Current & Future Analysis for Metaverse in Healthcare by End-user - Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Japan Historic Review for Metaverse in Healthcare by End-user - Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 88: Japan 8-Year Perspective for Metaverse in Healthcare by End-user - Percentage Breakdown of Value Sales for Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 89: Japan Recent Past, Current & Future Analysis for Metaverse in Healthcare by Technology - Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Japan Historic Review for Metaverse in Healthcare by Technology - Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 91: Japan 8-Year Perspective for Metaverse in Healthcare by Technology - Percentage Breakdown of Value Sales for Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies for the Years 2022, 2025 & 2030
  • CHINA
    • Metaverse in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 92: China Recent Past, Current & Future Analysis for Metaverse in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: China Historic Review for Metaverse in Healthcare by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 94: China 8-Year Perspective for Metaverse in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2025 & 2030
    • TABLE 95: China Recent Past, Current & Future Analysis for Metaverse in Healthcare by Application - Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: China Historic Review for Metaverse in Healthcare by Application - Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 97: China 8-Year Perspective for Metaverse in Healthcare by Application - Percentage Breakdown of Value Sales for Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training for the Years 2022, 2025 & 2030
    • TABLE 98: China Recent Past, Current & Future Analysis for Metaverse in Healthcare by End-user - Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: China Historic Review for Metaverse in Healthcare by End-user - Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 100: China 8-Year Perspective for Metaverse in Healthcare by End-user - Percentage Breakdown of Value Sales for Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 101: China Recent Past, Current & Future Analysis for Metaverse in Healthcare by Technology - Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: China Historic Review for Metaverse in Healthcare by Technology - Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 103: China 8-Year Perspective for Metaverse in Healthcare by Technology - Percentage Breakdown of Value Sales for Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies for the Years 2022, 2025 & 2030
  • EUROPE
    • Metaverse in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Metaverse in Healthcare by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for Metaverse in Healthcare by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 106: Europe 8-Year Perspective for Metaverse in Healthcare by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2022, 2025 & 2030
    • TABLE 107: Europe Recent Past, Current & Future Analysis for Metaverse in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Europe Historic Review for Metaverse in Healthcare by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 109: Europe 8-Year Perspective for Metaverse in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2025 & 2030
    • TABLE 110: Europe Recent Past, Current & Future Analysis for Metaverse in Healthcare by Application - Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Europe Historic Review for Metaverse in Healthcare by Application - Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 112: Europe 8-Year Perspective for Metaverse in Healthcare by Application - Percentage Breakdown of Value Sales for Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training for the Years 2022, 2025 & 2030
    • TABLE 113: Europe Recent Past, Current & Future Analysis for Metaverse in Healthcare by End-user - Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Europe Historic Review for Metaverse in Healthcare by End-user - Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 115: Europe 8-Year Perspective for Metaverse in Healthcare by End-user - Percentage Breakdown of Value Sales for Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 116: Europe Recent Past, Current & Future Analysis for Metaverse in Healthcare by Technology - Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Europe Historic Review for Metaverse in Healthcare by Technology - Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 118: Europe 8-Year Perspective for Metaverse in Healthcare by Technology - Percentage Breakdown of Value Sales for Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies for the Years 2022, 2025 & 2030
  • FRANCE
    • Metaverse in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 119: France Recent Past, Current & Future Analysis for Metaverse in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: France Historic Review for Metaverse in Healthcare by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 121: France 8-Year Perspective for Metaverse in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2025 & 2030
    • TABLE 122: France Recent Past, Current & Future Analysis for Metaverse in Healthcare by Application - Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: France Historic Review for Metaverse in Healthcare by Application - Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 124: France 8-Year Perspective for Metaverse in Healthcare by Application - Percentage Breakdown of Value Sales for Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training for the Years 2022, 2025 & 2030
    • TABLE 125: France Recent Past, Current & Future Analysis for Metaverse in Healthcare by End-user - Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: France Historic Review for Metaverse in Healthcare by End-user - Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 127: France 8-Year Perspective for Metaverse in Healthcare by End-user - Percentage Breakdown of Value Sales for Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 128: France Recent Past, Current & Future Analysis for Metaverse in Healthcare by Technology - Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: France Historic Review for Metaverse in Healthcare by Technology - Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 130: France 8-Year Perspective for Metaverse in Healthcare by Technology - Percentage Breakdown of Value Sales for Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies for the Years 2022, 2025 & 2030
  • GERMANY
    • Metaverse in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 131: Germany Recent Past, Current & Future Analysis for Metaverse in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Germany Historic Review for Metaverse in Healthcare by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 133: Germany 8-Year Perspective for Metaverse in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2025 & 2030
    • TABLE 134: Germany Recent Past, Current & Future Analysis for Metaverse in Healthcare by Application - Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Germany Historic Review for Metaverse in Healthcare by Application - Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 136: Germany 8-Year Perspective for Metaverse in Healthcare by Application - Percentage Breakdown of Value Sales for Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training for the Years 2022, 2025 & 2030
    • TABLE 137: Germany Recent Past, Current & Future Analysis for Metaverse in Healthcare by End-user - Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Germany Historic Review for Metaverse in Healthcare by End-user - Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 139: Germany 8-Year Perspective for Metaverse in Healthcare by End-user - Percentage Breakdown of Value Sales for Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 140: Germany Recent Past, Current & Future Analysis for Metaverse in Healthcare by Technology - Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Germany Historic Review for Metaverse in Healthcare by Technology - Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 142: Germany 8-Year Perspective for Metaverse in Healthcare by Technology - Percentage Breakdown of Value Sales for Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies for the Years 2022, 2025 & 2030
  • ITALY
    • TABLE 143: Italy Recent Past, Current & Future Analysis for Metaverse in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Italy Historic Review for Metaverse in Healthcare by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 145: Italy 8-Year Perspective for Metaverse in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2025 & 2030
    • TABLE 146: Italy Recent Past, Current & Future Analysis for Metaverse in Healthcare by Application - Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Italy Historic Review for Metaverse in Healthcare by Application - Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 148: Italy 8-Year Perspective for Metaverse in Healthcare by Application - Percentage Breakdown of Value Sales for Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training for the Years 2022, 2025 & 2030
    • TABLE 149: Italy Recent Past, Current & Future Analysis for Metaverse in Healthcare by End-user - Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Italy Historic Review for Metaverse in Healthcare by End-user - Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 151: Italy 8-Year Perspective for Metaverse in Healthcare by End-user - Percentage Breakdown of Value Sales for Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 152: Italy Recent Past, Current & Future Analysis for Metaverse in Healthcare by Technology - Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Italy Historic Review for Metaverse in Healthcare by Technology - Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 154: Italy 8-Year Perspective for Metaverse in Healthcare by Technology - Percentage Breakdown of Value Sales for Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies for the Years 2022, 2025 & 2030
  • UNITED KINGDOM
    • Metaverse in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 155: UK Recent Past, Current & Future Analysis for Metaverse in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: UK Historic Review for Metaverse in Healthcare by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 157: UK 8-Year Perspective for Metaverse in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2025 & 2030
    • TABLE 158: UK Recent Past, Current & Future Analysis for Metaverse in Healthcare by Application - Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: UK Historic Review for Metaverse in Healthcare by Application - Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 160: UK 8-Year Perspective for Metaverse in Healthcare by Application - Percentage Breakdown of Value Sales for Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training for the Years 2022, 2025 & 2030
    • TABLE 161: UK Recent Past, Current & Future Analysis for Metaverse in Healthcare by End-user - Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: UK Historic Review for Metaverse in Healthcare by End-user - Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 163: UK 8-Year Perspective for Metaverse in Healthcare by End-user - Percentage Breakdown of Value Sales for Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 164: UK Recent Past, Current & Future Analysis for Metaverse in Healthcare by Technology - Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: UK Historic Review for Metaverse in Healthcare by Technology - Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 166: UK 8-Year Perspective for Metaverse in Healthcare by Technology - Percentage Breakdown of Value Sales for Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies for the Years 2022, 2025 & 2030
  • REST OF EUROPE
    • TABLE 167: Rest of Europe Recent Past, Current & Future Analysis for Metaverse in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Europe Historic Review for Metaverse in Healthcare by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 169: Rest of Europe 8-Year Perspective for Metaverse in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2025 & 2030
    • TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for Metaverse in Healthcare by Application - Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Europe Historic Review for Metaverse in Healthcare by Application - Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 172: Rest of Europe 8-Year Perspective for Metaverse in Healthcare by Application - Percentage Breakdown of Value Sales for Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training for the Years 2022, 2025 & 2030
    • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Metaverse in Healthcare by End-user - Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Europe Historic Review for Metaverse in Healthcare by End-user - Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 175: Rest of Europe 8-Year Perspective for Metaverse in Healthcare by End-user - Percentage Breakdown of Value Sales for Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Metaverse in Healthcare by Technology - Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Europe Historic Review for Metaverse in Healthcare by Technology - Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 178: Rest of Europe 8-Year Perspective for Metaverse in Healthcare by Technology - Percentage Breakdown of Value Sales for Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies for the Years 2022, 2025 & 2030
  • ASIA-PACIFIC
    • Metaverse in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 179: Asia-Pacific Recent Past, Current & Future Analysis for Metaverse in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Asia-Pacific Historic Review for Metaverse in Healthcare by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 181: Asia-Pacific 8-Year Perspective for Metaverse in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2025 & 2030
    • TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for Metaverse in Healthcare by Application - Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Asia-Pacific Historic Review for Metaverse in Healthcare by Application - Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 184: Asia-Pacific 8-Year Perspective for Metaverse in Healthcare by Application - Percentage Breakdown of Value Sales for Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training for the Years 2022, 2025 & 2030
    • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Metaverse in Healthcare by End-user - Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Asia-Pacific Historic Review for Metaverse in Healthcare by End-user - Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 187: Asia-Pacific 8-Year Perspective for Metaverse in Healthcare by End-user - Percentage Breakdown of Value Sales for Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Metaverse in Healthcare by Technology - Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Asia-Pacific Historic Review for Metaverse in Healthcare by Technology - Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 190: Asia-Pacific 8-Year Perspective for Metaverse in Healthcare by Technology - Percentage Breakdown of Value Sales for Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies for the Years 2022, 2025 & 2030
  • REST OF WORLD
    • TABLE 191: Rest of World Recent Past, Current & Future Analysis for Metaverse in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of World Historic Review for Metaverse in Healthcare by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 193: Rest of World 8-Year Perspective for Metaverse in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2025 & 2030
    • TABLE 194: Rest of World Recent Past, Current & Future Analysis for Metaverse in Healthcare by Application - Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of World Historic Review for Metaverse in Healthcare by Application - Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 196: Rest of World 8-Year Perspective for Metaverse in Healthcare by Application - Percentage Breakdown of Value Sales for Drug Discovery & Personalized Medicine, Digital Therapeutics, Telehealth & Telemedicine, Other Applications and Medical Education & Surgical Training for the Years 2022, 2025 & 2030
    • TABLE 197: Rest of World Recent Past, Current & Future Analysis for Metaverse in Healthcare by End-user - Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of World Historic Review for Metaverse in Healthcare by End-user - Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 199: Rest of World 8-Year Perspective for Metaverse in Healthcare by End-user - Percentage Breakdown of Value Sales for Healthcare Providers, Patients, Pharma & Biopharma Companies and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 200: Rest of World Recent Past, Current & Future Analysis for Metaverse in Healthcare by Technology - Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of World Historic Review for Metaverse in Healthcare by Technology - Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2023 and % CAGR
    • TABLE 202: Rest of World 8-Year Perspective for Metaverse in Healthcare by Technology - Percentage Breakdown of Value Sales for Augmented / Virtual Reality, Artificial Intelligence, Blockchain, Mixed Reality and Other Technologies for the Years 2022, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제